Irinotecan liposome Intravenous and Liver impairment
Result of checking the interaction of drug Irinotecan liposome Intravenous and disease Liver impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The metabolism of irinotecan liposomal has not been evaluated. Irinotecan is primary metabolized by the liver to a biologically active metabolite. The pharmacokinetic disposition of irinotecan liposomal in patients with hepatic impairment has not been formally assessed. Therapy with irinotecan liposomal should be administered cautiously to patients with or predisposed to compromised hepatic function. Clinical monitoring of hepatic function is recommended.
Generic Name: irinotecan liposomal
Brand Name: Onivyde
Synonyms: Irinotecan liposomal, Irinotecan (Liposomal)